Skip to content
Recall Observatory FDA recall evidence

Drug product

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01

D-0567-2024

June 12, 2024

Class II

Product summary

Firm
PACIRA PHARMACEUTICALS INC
Event
Event 94791
Status
Ongoing
Classification
Class II
Quantity
40,517 kits
Official record key
drug-enforcement:D-0567-2024

Official wording

Reason: Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

Code information: Lot 23-9006; Expiry Date: MAR 2025

Distribution pattern: US Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications